RecruitingNot Applicable

Enhancing Diabetes Management Approaches for Patients With Uncontrolled Diabetes

United States376 participantsStarted 2024-02-03

Plain-language summary

The purpose of the study is to learn about the best way to enhance pharmacy-related care for diabetes self-management. This research is being done because we want to improve use of medicines and diabetes management among adults with type 2 diabetes and find out which of type of support may improve diabetes self-management for adults. Participants will be assigned to one of 4 groups, and will either: * receive care as usual; or, * receive added medicine management support from a pharmacist; or, * receive support from a Community Health Worker (CHW) to address life challenges; or, * receive both the pharmacist medicine management and the CHW support

Who can participate

Age range18 Years – 90 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Men and women ages 18-90 with diagnosed type 2 diabetes who speak and understand English or Spanish. * Taking at least one oral or injectable diabetes medication * HbA1c ≥ 7.5% based on point of care test. * Will reside in the geographical area throughout the study period. * Have access to a phone during the study period. * Willing to attend all orientation/training sessions. Exclusion Criteria: * Having a caregiver who is the main decision maker in self-management. * Participating in another lifestyle, or medication adherence program. * Participated in standard MTM/MTM-related intervention in the last 6 months. * Women who are pregnant or plan to get pregnant in the next 6 months.

What they're measuring

Change in mean hemoglobin A1c score

Timeframe: Baseline to 6 months

Change in mean hemoglobin A1c score

Timeframe: Baseline to 12 months

Trial details

NCT IDNCT05912647

SponsorUniversity of Wisconsin, Madison

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-12

Contact for this trial

Martha Maurer

608-265-2662 mamaurer@wisc.edu